LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹35 Cr | ₹43 Cr | ₹27 Cr | ₹20 Cr | ₹18 Cr |
What is the latest Sundry Debtors ratio of LYKA LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹35 Cr |
| Mar2025 | ₹43 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹18 Cr |
How is Sundry Debtors of LYKA LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹35 Cr | -18.67 | |
| Mar2025 | ₹43 Cr | 59.59 | |
| Mar2024 | ₹27 Cr | 34.12 | |
| Mar2023 | ₹20 Cr | 9.07 | |
| Mar2022 | ₹18 Cr | - | |
Compare Sundry Debtors of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹307.9 Cr | 5.2% | 18.1% | -16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 5.2% |
18.1% |
-16.1% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses